The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations
Open accessAbstract
Commercialization of protein‐based therapeutics is a challenging task in part due to the difficulties in maintaining protein solutions safe and efficacious throughout the drug product development process, storage, transportation and patient administration. Bulk drug substance goes through a series of formulation, fill and finish operations to provide the final dosage form in the desired formulation and container or delivery device. Different process parameters during each of these operations can affect the purity, activity and efficacy of the final product. Common protein degradation pathways and the various physical and chemical factors that can induce such reactions have been extensively studied for years. This review presents an overview of the various formulation‐fill‐finish operations with a focus on processing steps and conditions that can impact product quality. Various manufacturing operations including bulk freeze‐thaw, formulation, filtration, filling, lyophilization, inspection, labeling, packaging, storage, transport and delivery have been reviewed. The article highlights our present day understanding of protein instability issues during biopharmaceutical manufacturing and provides guidance on process considerations that can help alleviate these concerns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Privalov, P. L. (1990) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239009090612 · Cited by 1,071
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice
Tang, X., & Pikal, M. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016234.73023.75 · Cited by 972
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Principles of protein folding, misfolding and aggregation
Dobson, C. M. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.008 · Cited by 904
Oxidation of methionyl residues in proteins: Tools, targets, and reversal
Vogt, W. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00158-g · Cited by 883
Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
Carpenter, J. F., Pikal, M. J., Chang, B. S., & Randolph, T. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012180707283 · Cited by 683
Factors affecting short-term and long-term stabilities of proteins
Arakawa, T., Prestrelski, S. J., Kenney, W. C., & Carpenter, J. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00144-7 · Cited by 640
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Surface-Induced Denaturation of Proteins during Freezing and its Inhibition by Surfactants
Chang, B. S., Kendrick, B. S., & Carpenter, J. F. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960080y · Cited by 476
Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins
Sinclair, A. M., & Elliott, S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20319 · Cited by 461
Photo-oxidation of proteins and its role in cataractogenesis
Davies, M. J., & Truscott, R. J. W. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00208-1 · Cited by 448
Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions
Cao, E., Chen, Y., Cui, Z., & Foster, P. R. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10612 · Cited by 387
BSA structural changes during homomolecular exchange between the adsorbed and the dissolved states
Norde, W., & Giacomelli, C. E. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00242-x · Cited by 367
Protect from Light: Photodegradation and Protein Biologics
Kerwin, B. A., & Remmele, R. L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20815 · Cited by 354
Protein denaturation by combined effect of shear and air-liquid interface
Maa, Y.-F., & Hsu, C. C. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970620)54:6<503::aid-bit1>3.0.co;2-n · Cited by 348
Speed, M. A., Wang, D. I. C., & King, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1096-1283 · Cited by 312
Induction and analysis of aggregates in a liquid IgG1-antibody formulation
Mahler, H.-C., Müller, R., Frieβ, W., Delille, A., & Matheus, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.004 · Cited by 309
Effects of Tween 20® and Tween 80® on the Stability of Albutropin During Agitation
Chou, D. K., Krishnamurthy, R., Randolph, T. W., Carpenter, J. F., & Manning, M. C. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20365 · Cited by 307
Proteins in frozen solutions: evidence of ice-induced partial unfolding
Strambini, G. B., & Gabellieri, E. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79640-6 · Cited by 306
Silicone Oil Induced Aggregation of Proteins
Jones, L. S., Kaufmann, A., & Middaugh, C. R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20321 · Cited by 285
Kinetics and Thermodynamics of Amyloid Fibril Assembly
Wetzel, R. (2006) · Accounts of Chemical Research · doi:10.1021/ar050069h · Cited by 284
Rational Design of Stable Lyophilized Protein Formulations: Theory and Practice
Carpenter, J. F., Chang, B. S., Garzon-Rodriguez, W., & Randolph, T. W. (2002) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-0557-0_5 · Cited by 282
Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
Specificity in intracellular protein aggregation and inclusion body formation
Rajan, R. S., Illing, M. E., Bence, N. F., & Kopito, R. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181479798 · Cited by 237
Self-citationKrielgaard, L., Jones, L. S., Randolph, T. W., Frokjaer, S., Flink, J. M., Manning, M. C., & Carpenter, J. F. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980126i · Cited by 232
Radical-Mediated Protein Oxidation: From Chemistry to Medicine
Davies, M. J., & Dean, R. T. (1997) · doi:10.1093/oso/9780198500971.001.0001 · Cited by 218
Liu, J., Andya, J. D., & Shire, S. J. (2006) · The AAPS Journal · doi:10.1208/aapsj080367 · Cited by 202
Dityrosine: In vitro production and characterization
Amadò, R., Aeschbach, R., & Neukom, H. (1984) · Methods in Enzymology · doi:10.1016/0076-6879(84)07026-9 · Cited by 176
Capillary electrophoresis of proteins 2003–2005
Dolník, V. (2005) · Electrophoresis · doi:10.1002/elps.200500567 · Cited by 157
Spray-drying of trypsin — surface characterisation and activity preservation
Millqvist‐Fureby, A., Malmsten, M., & Bergenståhl, B. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00226-4 · Cited by 147
Pikal‐Cleland, K. A., Cleland, J. L., Anchordoquy, T. J., & Carpenter, J. F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10184 · Cited by 144
Application of infrared spectroscopy to development of stable lyophilized protein formulations
Carpenter, J. F., Prestrelski, S. J., & Dong, A. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00005-8 · Cited by 142
Bhatnagar, B. S., Pikal, M. J., & Bogner, R. H. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21017 · Cited by 124
Rehder, D. S., Dillon, T. M., Pipes, G. D., & Bondarenko, P. V. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.10.053 · Cited by 120
Photochemistry of proteins: a Review
Grossweiner, L. I. (1984) · Current Eye Research · doi:10.3109/02713688408997195 · Cited by 119
Chu, G. C., Chelius, D., Xiao, G., et al. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9241-4 · Cited by 111
The LC/MS Analysis of Glycation of IGG Molecules in Sucrose Containing Formulations
Gadgil, H. S., Bondarenko, P. V., Pipes, G. D., Rehder, D., McAuley, A., Perico, N., Dillon, T., Ricci, M. S., & Treuheit, M. J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20966 · Cited by 106
Protein formulation and fill-finish operations
Patro, S. Y., Freund, E., & Chang, B. S. (2002) · Biotechnology annual review · doi:10.1016/s1387-2656(02)08004-3 · Cited by 105
ChemInform Abstract: Freeze‐Drying of Proteins. Process, Formulation, and Stability.
Pikal, M. J. (1995) · ChemInform · doi:10.1002/chin.199504315 · Cited by 105
Stabilisation of dissolved proteins against denaturation at hydrophobie interfaces
Thurow, H., & Geisen, K. (1984) · Diabetologia · doi:10.1007/bf00273809 · Cited by 99
Immunogenicity of therapeutic proteins. Part 2: Impact of container closures
Sharma, B. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.01.006 · Cited by 98
Protein−solute interactions affect the outcome of ultrafiltration/diafiltration operations
Stoner, M. R., Fischer, N., Nixon, L., Buckel, S. D., Benke, M., Austin, F., Randolph, T. W., & Kendrick, B. S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20145 · Cited by 80
Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate
Remmele, R. L., Callahan, W. J., Krishnan, S., Zhou, L., Bondarenko, P. V., Nichols, A. C., Kleemann, G. R., Pipes, G. D., Park, S., Fodor, S., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20515 · Cited by 64
Mahler, H., Printz, M., Kopf, R., Schuller, R., & Müller, R. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21029 · Cited by 64
Bai, S., Nayar, R., Carpenter, J. F., & Manning, M. C. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20416 · Cited by 49
Schwegman, J. J., Carpenter, J. F., & Nail, S. L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20630 · Cited by 30
Cited by
Improving Protein Expression, Stability, and Function with ProteinMPNN
(2024) · doi:10.1021/jacs.3c10941 · Cited by 344
Corchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., et al. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.001 · Cited by 133
Correia, M., Neves-Petersen, M. T., Jeppesen, P. B., Gregersen, S., & Petersen, S. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050733 · Cited by 132
Metadata
- Authors
- Rathore, N., & Rajan, R. S.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2008-05
- Volume
- 24
- Issue
- 3
- Pages
- 504-514
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2118107894
- Cited by
- 289
- References
- 47
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.